Migraine

Migraine affects about 12% of people worldwide. Chronic migraine impacts 1% to 2% of the global population. Approximately 2.5% of individuals with episodic migraine develop chronic migraine. There are several risk factors linked to this progression. Migraine frequency shows significant short-term variability that isn't influenced by treatment. This condition is also linked to cardiovascular disease, psychiatric disorders, and sleep issues. Migraine is the second most disabling condition globally. Chronic migraine leads to greater headache-related disability and impact. It is associated with various medical and psychiatric comorbidities. Health care resource use, costs, and lower socioeconomic status are also significant factors. Additionally, chronic migraine affects health-related quality of life negatively. Understanding these aspects is crucial for managing and treating migraine effectively. This research highlights the complex nature of migraine and its broader implications for health. Clinical relevance: This research identifies the serious impact of chronic migraine on patients' lives.